IND – The Institute for Neurodegenerative Disorders

The MSPRF sponsored research at the IND is conducted under the direction of Yale Professors Dr. Jamie Hartley and Dr. John Seibyl. This lab is developing novel tools for early detection and monitoring of Parkinson’s disease by studying physiologic, biochemical and neuroimaging biomarkers for non-dominergic manifestations of Parkinsonism.
The IND has been active in the expansion of Amadeus (American and European Union SPECT Imaging Consortium) to continue the application of rigorous, standardized quantitative neuroimaging technology in multi-center trials to improve diagnosis and evaluate treatments for Parkinson disease and related disorders. They have initiated a multi-site study to develop smell testing and brain imaging as a potential tool for early diagnosis of Parkinson disease.

The IND will continue its research and development of new ligands/biomarkers for neurodegenerative disorders for Parkinson disease, and other neurological disorders.